Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.030
-0.020 (-0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
Stereotaxis Employees
Stereotaxis had 122 employees as of December 31, 2023. The number of employees decreased by 8 or -6.15% compared to the previous year.
Employees
122
Change (1Y)
-8
Growth (1Y)
-6.15%
Revenue / Employee
$206,090
Profits / Employee
-$187,648
Market Cap
172.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
The Joint | 794 |
2seventy bio | 274 |
Gossamer Bio | 135 |
MediWound | 100 |
Lineage Cell Therapeutics | 75 |
DiaMedica Therapeutics | 19 |
Galectin Therapeutics | 14 |
STXS News
- 1 day ago - Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewsWire
- 9 days ago - Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Stereotaxis Reports 2024 Third Quarter Financial Results - GlobeNewsWire
- 4 weeks ago - Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress - GlobeNewsWire
- 3 months ago - Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval - Seeking Alpha
- 3 months ago - Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript - Seeking Alpha